In the mIHC, the CCA, marked by CK19, EPCAM and CD44 was observed, further indicating an increase in the CCA and heightened tumor malignancy in DEN + MSCs group (Fig. 3G). This evidence concerns the gene EPCAM and cholangiocarcinoma.